Royal Bank of Canada

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
24,810
Total Value
350517986000
Accession Number
0001140361-25-019231
Form Type
13F-HR
Manager Name
Royal Bank of Canada
Data Enrichment
78% identified
19,259 identified5,551 unidentified

Holdings

24,810 positions
Manager:
Search and click to pin securities to the top
Page 290 of 331
74933W874
Shares:
317(-45.1%)
Value:
$10.0M(-52.4%)
46641Q266
Shares:
257(-65.9%)
Value:
$10.0M(-64.3%)
Legend Biotech Corp
Shares:
300(-62.5%)
Value:
$10.0M(-61.5%)
Nerdy Inc.
Shares:
7223(-2.5%)
Value:
$10.0M(-16.7%)
Flaherty & Crumrine PREFERRED & INCOME OPPORTUNITY FUND INC
Shares:
1050(+10.5%)
Value:
$10.0M(+11.1%)
Perion Network Ltd.
Shares:
1257
Value:
$10.0M
69374H659
Shares:
256(-38.0%)
Value:
$10.0M(-37.5%)
Celldex Therapeutics, Inc.
Shares:
564(-81.4%)
Value:
$10.0M(-86.8%)
Definitive Healthcare Corp.
Shares:
3357
Value:
$10.0M
BrightSpring Health Services, Inc.
Shares:
0
Value:
$10.0M(-33.3%)
EVOLUTION PETROLEUM CORP
Shares:
2047(-49.9%)
Value:
$10.0M(-52.4%)
46436E429
Shares:
500(-67.2%)
Value:
$10.0M(-64.3%)
Bitwise Bitcoin ETF
Shares:
200(-98.9%)
Value:
$9.0M(-99.0%)
00774Q346
Shares:
252
Value:
$9.0M
NET Power Inc.
Shares:
3129(-81.2%)
Value:
$9.0M(-94.9%)
OFS Capital Corp
Shares:
1000(+0.0%)
Value:
$9.0M(+12.5%)
Amplitude, Inc.
Shares:
878(-68.8%)
Value:
$9.0M(-70.0%)
LENSAR, Inc.
Shares:
608
Value:
$9.0M
Acumen Pharmaceuticals, Inc.
Shares:
8540(-41.8%)
Value:
$9.0M(-64.0%)
02072L433
Shares:
291
Value:
$9.0M